JPMorgan Chase is a best-in-class, universally diversified financial institution with a fortress balance sheet, consistent market share gains across cycles, and scale advantages that provide a structural premium over peers. Fair value range: low $190, high $324, with mid-point at $263.
Ten raport nie został jeszcze przetłumaczony. Odśwież za kilka minut, gdy kolejka tłumaczeń go przetworzy.
§1 Podsumowanie wykonawcze
Best-in-class financial institution trading at a 23% premium to our $263.06 fair value.
Near-term momentum and massive deposit franchise are already priced in.
Vulnerable to macroeconomic contraction, credit deterioration, and aggressive rate cuts.
Current valuation reflects peak-cycle margins and low credit costs.
Recommend reducing exposure as downside risks outweigh near-term upside.
Fair value
$263
Margin of safety
-16.4%
Confidence
88/100
Moat
9/10
Educational analysis only — not financial advice. Always do your own due diligence.
$306.27Price
FV $263.06
High $323.59
JPMorgan Chase is a best-in-class, universally diversified financial institution with a fortress balance sheet, consistent market share gains across cycles, and scale advantages that provide a structural premium over peers.
Scale advantage
Scale advantage
Switching costs
Switching costs
Cycle upside
Higher-for-longer rates supporting NII, robust capital markets activity, and benign credit environment.
§2 Scenariusz negatywny
A synchronized shock of a deep recession and aggressive rate cuts would severely impact both credit costs and NII. JPM's fortress balance sheet prevents existential risk, but earnings power would materially contract.
Jak ta teza może się załamać
Severe Credit Cycle Reversion
25%· Medium
A severe macroeconomic contraction leads to broad credit deterioration, spiking provisions for credit losses across consumer and commercial portfolios.
FV impact
Drops to $189.56
Trigger
12-18 months
Aggressive NIM Compression
15%· Low
Aggressive central bank rate cuts simultaneously compress net interest margins significantly faster than the market anticipates.
FV impact
Drops to $220.00
Trigger
6-12 months
Regulatory Capital Squeeze
10%· Low
Basel III Endgame and other regulatory changes severely constrain capital return, lowering the dividend payout and reducing structural ROE.
FV impact
Drops to $240.00
Trigger
24 months
Sygnały wczesnego ostrzegania do monitorowania
Wskaźnik
Bieżący
Próg wyzwalania
Consecutive quarters of net charge-offs exceeding 1.5%.
Monitor
Deterioration versus the report thesis
NIM compression exceeding 20 basis points sequentially.
Monitor
Deterioration versus the report thesis
Significant deceleration in consumer credit card spend volume.
Monitor
Deterioration versus the report thesis
Upward revision in Basel III capital requirements.
Monitor
Deterioration versus the report thesis
Deposit beta accelerating faster than asset yields during easing.
Monitor
Deterioration versus the report thesis
§3 Historia finansowa
Rachunek zysków i strat — ostatnich sześć okresów
Pozycja
T−0
T−1
T−2
T−3
T−4
CAGR
Okres
2021-12-31
2022-12-31
2023-12-31
2024-12-31
2025-12-31
Trend
Przychody
$121.65B
$128.70B
$158.10B
$177.56B
$182.45B
+10.7%
Zysk brutto
—
—
—
—
—
—
Zysk operacyjny
—
—
—
—
—
—
Zysk netto
$48.33B
$37.68B
$49.55B
$58.47B
$57.05B
+4.2%
EPS (rozwodniony)
$15.36
$12.09
$16.23
$19.75
$20.02
+6.8%
EBITDA
—
—
—
—
—
—
R&D
—
—
—
—
—
—
SG&A
—
$45.55B
$51.06B
$56.33B
$60.02B
+7.1%
Wyniki jakości
OCF / Zysk netto
-2.59
>1 wskazuje wysoką jakość wyników
Bramka jakości księgowej
Pass
Bramka skorygowana o sektor
ROIC
—
Zwrot z zainwestowanego kapitału
Sekcja 3
Numbers analysis
Przepływy pieniężne
Cash-flow quality is reflected in the OCF / net income, accounting-quality, and ROIC rows above.
Alokacja kapitału
Capital allocation should be evaluated against reinvestment needs, balance-sheet strength, and shareholder returns.
Subskrybenci indywidualni — od §411 kolejnych sekcji
Przeczytaj pełną analizę — 11 kolejnych sekcji.
Competitive moat, industry cycle, peer comparison, intrinsic valuation, sensitivity, scenarios, earnings decision tree, position management, investor perspectives, scorecard, and final recommendation.
Based on our latest independent analysis, JPM screens modestly overvalued. The current price is $306 versus a composite fair-value midpoint of $263 (range $190–$324), which implies roughly 14.1% downside to the midpoint.
Our composite fair-value range for JPM is $190–$324, with a midpoint of $263. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for JPMorgan Chase & Co.'s archetype.
Our current rating for JPM is Reduce with a confidence score of 88/100. Reduce rating. Fair value $263.06. This is independent research for educational purposes, not personalized investment advice.
The top risks our latest report flags for JPMorgan Chase & Co. are: Severe Credit Cycle Reversion; Aggressive NIM Compression; Regulatory Capital Squeeze. The single biggest risk is Severe Credit Cycle Reversion: A severe macroeconomic contraction leads to broad credit deterioration, spiking provisions for credit losses across consumer and commercial portfolios.
Our current rating for JPM is Reduce, issued with a confidence score of 88/100 and a moat score of 9/10. The rating reflects the composite fair-value range ($190–$324) versus the current price of $306.
JPMorgan Chase & Co. is classified as a financial stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for JPM.
